134 related articles for article (PubMed ID: 11396146)
1. Alternative splicing of fibronectin transcripts in osteochondrogenic tumors.
Matsui Y; Nakata K; Araki N; Ozono K; Fujita Y; Tsumaki N; Kawabata H; Yasui N; Sekiguchi K; Yoshikawa H
Anticancer Res; 2001; 21(2A):1103-6. PubMed ID: 11396146
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of VEGF isoforms and VEGF receptors in cartilaginous tumors.
Yukata K; Matsui Y; Goto T; Kubo T; Yasui N
Anticancer Res; 2005; 25(2A):955-7. PubMed ID: 15868933
[TBL] [Abstract][Full Text] [Related]
3. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors.
Sawyer JR; Swanson CM; Lukacs JL; Nicholas RW; North PE; Thomas JR
Cancer; 1998 Feb; 82(3):474-83. PubMed ID: 9452264
[TBL] [Abstract][Full Text] [Related]
4. Fibronectin mRNA alternative splicing is temporally and spatially regulated during chondrogenesis in vivo and in vitro.
Gehris AL; Oberlender SA; Shepley KJ; Tuan RS; Bennett VD
Dev Dyn; 1996 Jun; 206(2):219-30. PubMed ID: 8725289
[TBL] [Abstract][Full Text] [Related]
5. Alternative splicing of fibronectin mRNAs in chondrosarcoma cells: role of far upstream intron sequences.
Flanagan M; Liang H; Norton PA
J Cell Biochem; 2003 Nov; 90(4):709-18. PubMed ID: 14587027
[TBL] [Abstract][Full Text] [Related]
6. Coordinate oncodevelopmental modulation of alternative splicing of fibronectin pre-messenger RNA at ED-A, ED-B, and CS1 regions in human liver tumors.
Oyama F; Hirohashi S; Sakamoto M; Titani K; Sekiguchi K
Cancer Res; 1993 May; 53(9):2005-11. PubMed ID: 8481903
[TBL] [Abstract][Full Text] [Related]
7. Cartilage-forming tumors.
Qasem SA; DeYoung BR
Semin Diagn Pathol; 2014 Jan; 31(1):10-20. PubMed ID: 24680178
[TBL] [Abstract][Full Text] [Related]
8. Expression of EDA+ and EDB+ fibronectin splice variants in bone.
Kilian O; Dahse R; Alt V; Zardi L; Rosenhahn J; Exner U; Battmann A; Schnettler R; Kosmehl H
Bone; 2004 Dec; 35(6):1334-45. PubMed ID: 15589214
[TBL] [Abstract][Full Text] [Related]
9. Splicing patterns of type XI collagen transcripts act as molecular markers for osteochondrogenic tumors.
Matsui Y; Kimura T; Tsumaki N; Nakata K; Yasui N; Araki N; Hashimoto N; Uchida A; Ochi T
Cancer Lett; 1998 Feb; 124(2):143-8. PubMed ID: 9500203
[TBL] [Abstract][Full Text] [Related]
10. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
Tallini G; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Sciot R; Van den Berghe H; Vanni R; Willén H
J Pathol; 2002 Feb; 196(2):194-203. PubMed ID: 11793371
[TBL] [Abstract][Full Text] [Related]
11. Changes in the pattern of fibronectin mRNA alternative splicing in acute experimental mesangioproliferative nephritis.
Alonso J; Mampaso F; Martín A; Palacios I; Egido J
Lab Invest; 1999 Feb; 79(2):185-94. PubMed ID: 10068206
[TBL] [Abstract][Full Text] [Related]
12. [On the morphologic characteristics of chondrosarcoma and osteogenic sarcomas].
Shperling ID
Arkh Patol; 1967; 29(8):68-73. PubMed ID: 5246010
[No Abstract] [Full Text] [Related]
13. Cartilage- and bone-forming tumors of the soft tissues.
Reiman HM; Dahlin DC
Semin Diagn Pathol; 1986 Nov; 3(4):288-305. PubMed ID: 3303235
[TBL] [Abstract][Full Text] [Related]
14. Oncodevelopmental regulation of the alternative splicing of fibronectin pre-messenger RNA in human lung tissues.
Oyama F; Hirohashi S; Shimosato Y; Titani K; Sekiguchi K
Cancer Res; 1990 Feb; 50(4):1075-8. PubMed ID: 2297755
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of aggrecan mRNA isoforms by chondrosarcoma cells.
Matsui Y; Araki N; Tsuboi H; Tsumaki N; Nakata K; Kawabata H; Eyre DR; Yoshikawa H
Anticancer Res; 2002; 22(6C):4169-72. PubMed ID: 12553050
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of borderline cartilage lesions of bone.
Schiller AL
Semin Diagn Pathol; 1985 Feb; 2(1):42-62. PubMed ID: 3870763
[TBL] [Abstract][Full Text] [Related]
17. IDH1 mutations are not found in cartilaginous tumours other than central and periosteal chondrosarcomas and enchondromas.
Damato S; Alorjani M; Bonar F; McCarthy SW; Cannon SR; O'Donnell P; Tirabosco R; Amary MF; Flanagan AM
Histopathology; 2012 Jan; 60(2):363-5. PubMed ID: 22074484
[No Abstract] [Full Text] [Related]
18. Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan.
Muro AF; Chauhan AK; Gajovic S; Iaconcig A; Porro F; Stanta G; Baralle FE
J Cell Biol; 2003 Jul; 162(1):149-60. PubMed ID: 12847088
[TBL] [Abstract][Full Text] [Related]
19. Alternative promoter usage and alternative splicing contribute to mRNA heterogeneity of mouse monocarboxylate transporter 2.
Zhang SX; Searcy TR; Wu Y; Gozal D; Wang Y
Physiol Genomics; 2007 Dec; 32(1):95-104. PubMed ID: 17911380
[TBL] [Abstract][Full Text] [Related]
20. Impaired motor coordination in mice lacking the EDA exon of the fibronectin gene.
Chauhan AK; Moretti FA; Iaconcig A; Baralle FE; Muro AF
Behav Brain Res; 2005 Jun; 161(1):31-8. PubMed ID: 15904707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
